A detailed history of Russell Investments Group, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 241,102 shares of AMGN stock, worth $76.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
241,102
Previous 255,330 5.57%
Holding current value
$76.2 Million
Previous $72.6 Million 3.77%
% of portfolio
0.12%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $3.74 Million - $4.54 Million
-14,228 Reduced 5.57%
241,102 $75.3 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $5.02 Million - $6.05 Million
18,655 Added 7.88%
255,330 $72.6 Million
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $5.25 Million - $5.93 Million
-20,545 Reduced 7.99%
236,675 $68.2 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $15.7 Million - $19.5 Million
-71,805 Reduced 21.82%
257,220 $69.1 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $25.3 Million - $29.9 Million
-117,889 Reduced 26.38%
329,025 $73.1 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $2.02 Million - $2.46 Million
8,957 Added 2.05%
446,914 $108 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $6.28 Million - $7.98 Million
27,430 Added 6.68%
437,957 $115 Million
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $10.6 Million - $11.9 Million
47,180 Added 12.98%
410,527 $92.9 Million
Q2 2022

Jul 29, 2022

SELL
$230.71 - $256.74 $4.62 Million - $5.14 Million
-20,025 Reduced 5.22%
363,347 $88.6 Million
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $1.07 Million - $1.18 Million
4,875 Added 1.29%
383,372 $92.8 Million
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $6.53 Million - $7.47 Million
-32,839 Reduced 7.98%
378,497 $85.2 Million
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $2.54 Million - $2.97 Million
-11,957 Reduced 2.82%
411,336 $87.7 Million
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $1.79 Million - $1.99 Million
7,661 Added 1.84%
423,293 $103 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $10.8 Million - $12.5 Million
48,511 Added 13.21%
415,632 $103 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $2.77 Million - $3.3 Million
-12,803 Reduced 3.37%
367,121 $83.9 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $13 Million - $14.5 Million
-55,518 Reduced 12.75%
379,924 $95.5 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $1.48 Million - $1.81 Million
-7,473 Reduced 1.69%
435,442 $102 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $5.93 Million - $7.86 Million
-32,524 Reduced 6.84%
442,915 $90.6 Million
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $1.28 Million - $1.65 Million
6,776 Added 1.45%
475,439 $114 Million
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $9.67 Million - $11.6 Million
-55,512 Reduced 10.59%
468,663 $90.9 Million
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $14.5 Million - $17 Million
86,771 Added 19.84%
524,175 $96.6 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $5.49 Million - $6.19 Million
30,347 Added 7.46%
437,404 $82.9 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $3.35 Million - $3.91 Million
-18,752 Reduced 4.4%
407,057 $78.8 Million
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $2.45 Million - $2.76 Million
-13,222 Reduced 3.01%
425,809 $88.5 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $10.1 Million - $11.4 Million
-60,959 Reduced 12.19%
439,031 $80.8 Million
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $21.5 Million - $25.1 Million
126,746 Added 33.96%
499,990 $85 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $32.9 Million - $36.8 Million
-194,889 Reduced 34.3%
373,244 $65.4 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $95 Million - $109 Million
568,133
568,133 $106 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.